United States voluntary children’s chemical evaluation program (VCCEP) risk assessment for children exposed to benzene

References

• ACC. 2006. Voluntary Children’s Chemical Evaluation Program (VCCEP) Tier 1 Pilot Submission for Benzene. Docket Number OPPTS-00274D.: American Chemistry Council.
   Google Scholar
• ACGIH. 2001. Documentation of the Threshold Limit Value for Benzene. American Conference of Governmental Industrial Hygienists. American Conference of Governmental Industrial Hygienists.
   Google Scholar
• Adgate JL, Church TR, Ryan AD, Ramachandran G, Fredrickson AL, Stock TH, Morandi MT, Sexton K. 2004. Outdoor, indoor, and personal exposure to VOCs in children. Environ Health Perspect 112:1386–1392.
   PubMed Web of Science ®Google Scholar
• Adgate JL, Eberly LE, Stroebel C, Pellizzari ED, Sexton K. 2004. Personal, indoor, and outdoor VOC exposures in a probability sample of children. J Expo Anal Environ Epidemiol 14 Suppl 1:S4–S13.
   Google Scholar
• Aksoy M. 1977. Leukemia in workers due to occupational exposure to benzene. New Istanbul Contrib Clin Sci 12:3–14.
   PubMedGoogle Scholar
• Aksoy M. 1980. Malignancies due to occupational exposure to benzene. Haematologica 65:370–373.
   PubMedGoogle Scholar
• Aksoy M, Erdem S. 1978. Followup study on the mortality and the development of leukemia in 44 pancytopenic patients with chronic exposure to benzene. Blood 52:285–292.
   PubMed Web of Science ®Google Scholar
• Andersen M, Sarangapani R, Gentry R, Clewell H, Covington T, Frederick CB. 2000. Application of a hybrid CFD-PBPK nasal dosimetry model in an inhalation risk assessment: an example with acrylic acid. Toxicol Sci 57:312–325.
   PubMed Web of Science ®Google Scholar
• Bird MG, Greim H, Snyder R, Rice JM. 2005. International symposium: Recent advances in benzene toxicity. Chem Biol Interact 153-154:1–5.
   Google Scholar
• Bloemen LJ, Youk A, Bradley TD, Bodner KM, Marsh G. 2004. Lymphohaematopoietic cancer risk among chemical workers exposed to benzene. Occup Environ Med 61:270–274.
   PubMedGoogle Scholar
• Bond GG, McLaren EA, Baldwin CL, Cook RR. 1986. An update of mortality among chemical workers exposed to benzene. Br J Ind Med 43:685–691.
   PubMedGoogle Scholar
• Bond GG, McLaren EA, Cartmill JB, Wymer KT, Sobel W, Lipps TE, Cook RR. 1987. Cause-specific mortality among male chemical workers. Am J Ind Med 12:353–383.
   PubMedGoogle Scholar
• Bond GG, Shellenberger RJ, Fishbeck WA, Cartmill JB, Lasich BJ, Wymer KT, Cook RR. 1985. Mortality among a large cohort of chemical manufacturing employees. J Natl Cancer Inst 75:859–869.
   PubMedGoogle Scholar
• Brunnemann KD, Kagan MR, Cox JE, Hoffmann D. 1989. Determination of benzene, toluene and 1,3-butadiene in cigarette smoke by GC-MDS. Exp Pathol 37:108–113.
   PubMedGoogle Scholar
• Collins JJ, Ireland B, Buckley CF, Shepperly D. 2003. Lymphohaematopoeitic cancer mortality among workers with benzene exposure. Occup Environ Med 60:676–679.
   PubMed Web of Science ®Google Scholar
• Constantini AAE. 2001. A multi-center case-control study in Italy on hematolymphopoietic neoplasms and occupation. Epidemiology, 12, 78–87.
   Google Scholar
• Seniori Costantini A, Quinn M, Consonni D, Zappa M. 2003. Exposure to benzene and risk of leukemia among shoe factory workers. Scand J Work Environ Health 29:51–59.
   Google Scholar
• Cox LA Jr. 1996. Reassessing benzene risks using internal doses and Monte-Carlo uncertainty analysis. Environ Health Perspect, 104 Suppl 6, 1413–1429.
   Google Scholar
• Cox LA Jr, Ricci PF. 1992. Reassessing benzene cancer risks using internal doses. Risk Anal 12:401–410.
   PubMed Web of Science ®Google Scholar
• Crump, K. S. & Allen, B. C. 1984. Quantitative Estimates of Risk of Leukemia from Occupational Exposure to Benzene. Prepared for the Occupational Safety and Health Administration by Science Research Systems, Inc. Ruston, LA.: Unpublished.
   Google Scholar
• Darrall KG, Figgins JA, Brown RD, Phillips GF. 1998. Determination of benzene and associated volatile compounds in mainstream cigarette smoke. Analyst 123:1095–1101.
   PubMed Web of Science ®Google Scholar
• Donaldson SS. 1993. Lessons from our children. Int J Radiat Oncol Biol Phys 26:739–749.
   Google Scholar
• Dourson M. Modifying uncertainty factors for noncancer endpoints. In: Advanced Topics in Risk Assessment, Society of Toxicology 1993 Annual Meeting, 1993 New Orleans, LA.
   Google Scholar
• ECB. 2003. Risk assessment: Benzene. In: European chemicals bureau, T. A. C. S., institute for health and consumer protection, joint research centre, European commission (ed.).
   Google Scholar
• Forni A, Vigliani EC. 1974. Chemical leukemogenesis in man. Ser Haematol 7:211–223.
   Google Scholar
• Gerarde HW. 1959. Toxicological studies on hydrocarbons. III. The biochemorphology of the phenylalkanes and phenylalkenes. AMA Arch Ind Health 19:403–418.
   PubMedGoogle Scholar
• Glass DC, Gray CN, Jolley DJ, Gibbons C, Sim MR, Fritschi L, Adams GG, Bisby JA, Manuell R. 2003. Leukemia risk associated with low-level benzene exposure. Epidemiology 14:569–577.
   PubMed Web of Science ®Google Scholar
• Glaubiger DL, von Hoff DD, Holcenberg JS, Kamen B, Pratt C, Ungerleider RS. 1981. The relative tolerance of children and adults to anticancer drugs. Front Radiat Ther Oncol 16:42–49.
   Google Scholar
• Green JD, Snyder CA, LoBue J, Goldstein BD, Albert RE. 1981. Acute and chronic dose/response effect of benzene inhalation on the peripheral blood, bone marrow, and spleen cells of CD-1 male mice. Toxicol Appl Pharmacol 59:204–214.
   PubMed Web of Science ®Google Scholar
• Guénel P, Imbernon E, Chevalier A, Crinquand-Calastreng A, Goldberg M. 2002. Leukemia in relation to occupational exposures to benzene and other agents: a case-control study nested in a cohort of gas and electric utility workers. Am J Ind Med 42:87–97.
   PubMed Web of Science ®Google Scholar
• Hayes RB, Yin SN, Dosemeci M, Li GL, Wacholder S, Travis LB, Li CY, Rothman N, Hoover RN, Linet MS. 1997. Benzene and the dose-related incidence of hematologic neoplasms in China. Chinese Academy of Preventive Medicine–National Cancer Institute Benzene Study Group. J Natl Cancer Inst 89:1065–1071.
   PubMed Web of Science ®Google Scholar
• Infante PF, Rinsky RA, Wagoner JK, Young RJ. 1977. Leukaemia in benzene workers. Lancet 2:76–78.
   PubMed Web of Science ®Google Scholar
• Ireland B, Collins JJ, Buckley CF, Riordan SG. 1997. Cancer mortality among workers with benzene exposure. Epidemiology 8:318–320.
   PubMed Web of Science ®Google Scholar
• Irons RD. 1997. Leukemogenesis as a toxic response. In: Sipes IG, Mcqueen CA, Gandolfi AJ, Bloom JC. (eds.) Comprehensive Toxicology. New York: Elsevier Science Ltd.
   Google Scholar
• Irons RD, Gross SA, Le A, Wang XQ, Chen Y, Ryder J, Schnatter AR. 2010. Integrating WHO 2001-2008 criteria for the diagnosis of Myelodysplastic Syndrome (MDS): a case-case analysis of benzene exposure. Chem Biol Interact 184:30–38.
   PubMed Web of Science ®Google Scholar
• Irons RD, Lv L, Gross SA, Ye X, Bao L, Wang XQ, Ryder J, Armstrong TW, Zhou Y, Miao L, Le AT, Kerzic PJ, Ni W, Fu H. 2005. Chronic exposure to benzene results in a unique form of dysplasia. Leuk Res 29:1371–1380.
   PubMed Web of Science ®Google Scholar
• Irons RD, Stillman WS. 1993. Cell proliferation and differentiation in chemical leukemogenesis. Stem Cells 11:235–242.
   PubMed Web of Science ®Google Scholar
• Irons RD, Stillman WS, Colagiovanni DB, Henry VA. 1992. Synergistic action of the benzene metabolite hydroquinone on myelopoietic stimulating activity of granulocyte/macrophage colony-stimulating factor in vitro. Proc Natl Acad Sci USA 89:3691–3695.
   PubMed Web of Science ®Google Scholar
• Isbell M, Ricker J, Gordian ME, Duffy LK. 1999. Use of biomarkers in an indoor air study: lack of correlation between aromatic VOCs with respective urinary biomarkers. Sci Total Environ 241:151–159.
   Google Scholar
• Kaldor JM, Day NE, Clarke EA, Van Leeuwen FE, Henry-Amar M, Fiorentino MV, Bell J, Pedersen D, Band P, Assouline D. 1990. Leukemia following Hodgkin’s disease. N Engl J Med 322:7–13.
   PubMed Web of Science ®Google Scholar
• Kenyon EM, Kraichely RE, Hudson KT, Medinsky MA. 1996. Differences in rates of benzene metabolism correlate with observed genotoxicity. Toxicol Appl Pharmacol 136:49–56.
   PubMed Web of Science ®Google Scholar
• Kinney PL, Chillrud SN, Ramstrom S, Ross J, Spengler JD. 2002. Exposures to multiple air toxics in New York City. Environ Health Perspect 110 Suppl 4:539–546.
   Google Scholar
• Kipen HM, Cody RP, Crump KS, Allen BC, Goldstein BD. 1988. Hematologic effects of benzene: a thirty-five year longitudinal study of rubber workers. Toxicol Ind Health 4:411–430.
   PubMed Web of Science ®Google Scholar
• Kondo N, Takahashi A, Mori E, Ohnishi K, McKinnon PJ, Sakaki T, Nakase H, Ohnishi T. 2009. DNA ligase IV as a new molecular target for temozolomide. Biochem Biophys Res Commun 387:656–660.
   Google Scholar
• Kuttesch JF Jr, Wexler LH, Marcus RB, Fairclough D, Weaver-McClure L, White M, Mao L, Delaney TF, Pratt CB, Horowitz ME, Kun LE. 1996. Second malignancies after Ewing’s sarcoma: radiation dose-dependency of secondary sarcomas. J Clin Oncol 14:2818–2825.
   PubMed Web of Science ®Google Scholar
• Le Deley MC, Leblanc T, Shamsaldin A, Raquin MA, Lacour B, Sommelet D, Chompret A, Cayuela JM, Bayle C, Bernheim A, de Vathaire F, Vassal G, Hill C; Société Française d’Oncologie Pédiatrique. 2003. Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: a case-control study by the Société Française d’Oncologie Pédiatrique. J Clin Oncol 21:1074–1081.
   PubMed Web of Science ®Google Scholar
• Löning L, Zimmermann M, Reiter A, Kaatsch P, Henze G, Riehm H, Schrappe M. 2000. Secondary neoplasms subsequent to Berlin-Frankfurt-Münster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy. Blood 95:2770–2775.
   PubMed Web of Science ®Google Scholar
• Marsoni S, Ungerleider RS, Hurson SB, Simon RM, Hammershaimb LD. 1985. Tolerance to antineoplastic agents in children and adults. Cancer Treat Rep 69:1263–1269.
   PubMedGoogle Scholar
• Mauch PM, Kalish LA, Marcus KC, Coleman CN, Shulman LN, Krill E, Come S, Silver B, Canellos GP, Tarbell NJ. 1996. Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin’s disease: long-term analysis of risk factors and outcome. Blood 87:3625–3632.
   PubMed Web of Science ®Google Scholar
• McMahon TF, Medinsky MA, Birnbaum LS. 1994. Age-related changes in benzene disposition in male C57BL/6N mice described by a physiologically based pharmacokinetic model. Toxicol Lett 74:241–253.
   PubMedGoogle Scholar
• Meadows AT, Obringer AC, Marrero O, Oberlin O, Robison L, Fossati-Bellani F, Green D, Voûte PA, Morris-Jones P, Greenberg M. 1989. Second malignant neoplasms following childhood Hodgkin’s disease: treatment and splenectomy as risk factors. Med Pediatr Oncol 17:477–484.
   PubMedGoogle Scholar
• Morris S. Influence of Attached Garages on Indoor VOC Concentrations in Anchorage Homes. In: Presentation at the Annual Conference of the Pacific Northwest International Section of the Air & Waste Management Association., 2004 Portland, OR.
   Google Scholar
• Neglia JP, Friedman DL, Yasui Y, Mertens AC, Hammond S, Stovall M, Donaldson SS, Meadows AT, Robison LL. 2001. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst 93:618–629.
   PubMed Web of Science ®Google Scholar
• Ott WR, Roberts JW. 1998. Everyday exposure to toxic pollutants. Sci Am 278:86–91.
   PubMed Web of Science ®Google Scholar
• Paustenbach DJ, Price PS, Ollison W, Blank C, Jernigan JD, Bass RD, Peterson HD. 1992. Reevaluation of benzene exposure for the Pliofilm (rubberworker) cohort (1936-1976). J Toxicol Environ Health 36:177–231.
   PubMed Web of Science ®Google Scholar
• Paxton MB, Chinchilli VM, Brett SM, Rodricks JV. 1994. Leukemia risk associated with benzene exposure in the pliofilm cohort: I. Mortality update and exposure distribution. Risk Anal 14:147–154.
   PubMed Web of Science ®Google Scholar
• Pedersen-Bjergaard J, Specht L, Larsen SO, Ersbøll J, Struck J, Hansen MM, Hansen HH, Nissen NI. 1987. Risk of therapy-related leukaemia and preleukaemia after Hodgkin’s disease. Relation to age, cumulative dose of alkylating agents, and time from chemotherapy. Lancet 2:83–88.
   PubMed Web of Science ®Google Scholar
• Phillips ML, Esmen NA, Hall TA, Lynch R. 2004. Determinants of exposure to volatile organic compounds in four Oklahoma cities. Journal of Exposure Analysis and Environmental Epidemiology, 2004, 1–12.
   Google Scholar
• Pyatt DW, Aylward LL, Hays SM. 2007. Is age an independent risk factor for chemically induced acute myelogenous leukemia in children? J Toxicol Environ Health B Crit Rev 10:379–400.
   PubMed Web of Science ®Google Scholar
• Pyatt DW, Hays SM, Cushing CA. 2005. Do children have increased susceptibility for developing secondary acute myelogenous leukemia? Chem Biol Interact 153-154:223–229.
   Google Scholar
• Ries C, Loher F, Zang C, Ismair MG, Petrides PE. 1999. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes. Clin Cancer Res 5:1115–1124.
   PubMed Web of Science ®Google Scholar
• Rinsky RA, Smith AB, Hornung R, Filloon TG, Young RJ, Okun AH, Landrigan PJ. 1987. Benzene and leukemia. An epidemiologic risk assessment. N Engl J Med 316:1044–1050.
   PubMed Web of Science ®Google Scholar
• Rinsky RA, Young RJ, Smith AB. 1981. Leukemia in benzene workers. Am J Ind Med 2:217–245.
   PubMedGoogle Scholar
• Rothman N, Li GL, Dosemeci M, Bechtold WE, Marti GE, Wang YZ, Linet M, Xi LQ, Lu W, Smith MT, Titenko-Holland N, Zhang LP, Blot W, Yin SN, Hayes RB. 1996. Hematotoxicity among Chinese workers heavily exposed to benzene. Am J Ind Med 29:236–246.
   PubMed Web of Science ®Google Scholar
• Roy A, Weisel CP, Lioy PJ, Georgopoulos PG. 1996. A distributed parameter physiologically-based pharmacokinetic model for dermal and inhalation exposure to volatile organic compounds. Risk Anal 16:147–160.
   PubMed Web of Science ®Google Scholar
• Rushton L, Romaniuk H. 1997. A case-control study to investigate the risk of leukaemia associated with exposure to benzene in petroleum marketing and distribution workers in the United Kingdom. Occup Environ Med 54:152–166.
   PubMed Web of Science ®Google Scholar
• Santesson CG. 1897. Chronic poisoning with coal tar benzene: Four deaths. Clinical and pathological-anatomical observations of several colleagues and illustrating animal experiments. Arch Hyg (Munich), 31, 336–376.
   Google Scholar
• Schnatter AR, Armstrong TW, Nicolich MJ, Thompson FS, Katz AM, Huebner WW, Pearlman ED. 1996. Lymphohaematopoietic malignancies and quantitative estimates of exposure to benzene in Canadian petroleum distribution workers. Occup Environ Med 53:773–781.
   PubMed Web of Science ®Google Scholar
• Schnatter AR, Kerzic PJ, Zhou Y, Chen M, Nicholich MJ, Lavelle K, Armstrong TW, Bird MG, Lin L, Fu H, Irons R. 2010. Peripheral blood effects in benzene exposed workers. Chemico-Biological Interactions.
   Google Scholar
• Selling L. 1916. Benzol as a leucotoxin: studies on the degeneration and regeneration of the blood and haematopoietic organs. J H Med Rep, 17, 83–142.
   Google Scholar
• Sherwood RJ, Sinclair GC. 1999. New PBPK model applied to old occupational exposure to benzene. Am Ind Hyg Assoc J 60:259–265.
   PubMed Web of Science ®Google Scholar
• Snyder CA, Green JD, LoBue J, Goldstein BD, Valle CD, Albert RE. 1981. Protracted benzene exposure causes a proliferation of myeloblasts and/or promyelocytes in CD-1 mice. Bull Environ Contam Toxicol 27:17–22.
   PubMedGoogle Scholar
• Snyder R, Kalf GF. 1994. A perspective on benzene leukemogenesis. Crit Rev Toxicol 24:177–209.
   PubMed Web of Science ®Google Scholar
• Spear RC, Bois FY, Woodruff T, Auslander D, Parker J, Selvin S. 1991. Modeling benzene pharmacokinetics across three sets of animal data: parametric sensitivity and risk implications. Risk Anal 11:641–654.
   PubMed Web of Science ®Google Scholar
• Thomas RS, Bigelow PL, Keefe TJ, Yang RS. 1996. Variability in biological exposure indices using physiologically based pharmacokinetic modeling and Monte Carlo simulation. Am Ind Hyg Assoc J 57:23–32.
   PubMed Web of Science ®Google Scholar
• Thrall KD, Callahan PJ, Weitz KK, Edwards JA, Brinkman MC, Kenny DV. 2001. Design and evaluation of a breath-analysis system for biological monitoring of volatile compound. AIHAJ 62:28–35.
   PubMedGoogle Scholar
• Travis CC, Quillen JL, Arms AD. 1990. Pharmacokinetics of benzene. Toxicol Appl Pharmacol 102:400–420.
   PubMed Web of Science ®Google Scholar
• Tucker MA, Meadows AT, Boice JD Jr, Stovall M, Oberlin O, Stone BJ, Birch J, Voûte PA, Hoover RN, Fraumeni JF Jr. 1987. Leukemia after therapy with alkylating agents for childhood cancer. J Natl Cancer Inst 78:459–464.
   PubMed Web of Science ®Google Scholar
• US EPA. 1989. Risk assessment guidance for Superfund—Volume I: human health evaluation manual (Part A). Interim final. EPA/540/1- 89/002. In: U.S. ENVIRONMENTAL PROTECTION AGENCY, O. O. S. W. A. R. R. (ed.). Washington, DC.
   Google Scholar
• US EPA. 1990. National oil and hazardous substance pollution contigency plan. U.S. Environmental Protection Agency, Office of Solid Waste and Emergency Response. Washington, D.C. (40 CFR Part 300, revised March 1990).
   Google Scholar
• US EPA. 1991. Nonroad Engine and Vehicle Emission Study− Report. EPA 21A-2001. In: US EPA, O. O. A. A. R. (ed.). Washington, D.C.
   Google Scholar
• US EPA. 1998. Carcinogenic Effects of Benzene: An Update. National Center for Environmental Assessment.
   Google Scholar
• US EPA. 2003a. Integrated Risk Information System (IRIS). Online electronic data files (http://www.epa.gov/iris/subst/0276.htm). U.S. Environmental Protection Agency, Office of Research and Development National Center for Environmental Assessment, Cincinnati, OH.
   Google Scholar
• US EPA. 2003b. EPA TRI Explorer Report (USYR) - Releases Trends Report for Benzene. Accessed at: http://www.epa.gov/triexplorer/trends.htm.
   Google Scholar
• US EPA. 2005a. Guidelines for carcinogen risk assessment. EPA/630/P-03/001B. In: U.S. ENVIRONMENTAL PROTECTION AGENCY, R. A. F. (ed.). Washington, DC.
   Google Scholar
• US EPA. 2005b. Supplemental guidance for assessing susceptibility from early-life exposure to carcinogens. EPA/630/R-03/003F. In: U.S. environmental protection agency, R. A. F. (ed.). Washington, D.C.
   Google Scholar
• van der Velden JW, Van putten WL, Guinee VF, Pfeiffer R, Van Leeuwen FE, Van der linden EA, Vardomskaya I, Lane W, Durand M, Lagarde C et al. 1988. Subsequent development of acute non-lymphocytic leukemia in patients treated for Hodgkin’s disease. Int J Cancer 42, 252–255.
   PubMed Web of Science ®Google Scholar
• Vigliani EC. 1976. Leukemia associated with benzene exposure. Ann N Y Acad Sci 271:143–151.
   PubMed Web of Science ®Google Scholar
• Wallace LA. 1989. Major sources of benzene exposure. Environ Health Perspect 82:165–169.
   PubMed Web of Science ®Google Scholar
• Wallace LA. 1996. Environmental exposure to benzene: An update. Environ Health Perspect 104 (Suppl.6), 1129–1136.
   Google Scholar
• Wallace LA, Pellizzari ED, Hartwell TD, Whitmore R, Perritt R, Sheldon LS. 1988. The California TEAM study: breath concentrations and personal exposures to 26 volatile organic compounds in air and drinking water of 188 residents of Los Angeles, Antioch, and Pittsburg, CA. Atmos Environ 22, 2141–2163.
   Web of Science ®Google Scholar
• Weisel C, Yu R, Roy A, Georgopoulos P. 1996. Biomarkers of environmental benzene exposure. Environ Health Perspect 104 Suppl 6:1141–1146.
   Google Scholar
• WHO. 1993. International Programme on Chemical Safety, Environmental Health Criteria 150: Benzene. World Health Organization, Geneva.
   Google Scholar
• Williams PR, Paustenbach DJ. 2003. Reconstruction of benzene exposure for the Pliofilm cohort (1936-1976) using Monte Carlo techniques. J Toxicol Environ Health Part A 66:677–781.
   PubMed Web of Science ®Google Scholar
• Winick NJ, McKenna RW, Shuster JJ, Schneider NR, Borowitz MJ, Bowman WP, Jacaruso D, Kamen BA, Buchanan GR. 1993. Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide. J Clin Oncol 11:209–217.
   PubMed Web of Science ®Google Scholar
• Wong O. 1995. Risk of acute myeloid leukaemia and multiple myeloma in workers exposed to benzene. Occup Environ Med 52:380–384.
   PubMed Web of Science ®Google Scholar
• Wong O, Raabe GK. 1995. Cell-type-specific leukemia analyses in a combined cohort of more than 208,000 petroleum workers in the United States and the United Kingdom, 1937-1989. Regul Toxicol Pharmacol 21:307–321.
   PubMed Web of Science ®Google Scholar